Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2018-02-02 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于召开2018年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2018 first extraordinary general meeting (临时股东大会) of Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), registration details, agenda items (such as adjusting the number of board members and amending the Articles of Association), and attachments like proxy forms and voting instructions. There is no financial data, earnings information, or audit content. The document is not a report itself but a notice about the meeting and how shareholders can participate and vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document is about a shareholder meeting and voting, not the voting results, so it is not a Declaration of Voting Results (DVA). It is also not a Board/Management Information announcement since it is about the meeting itself, not management changes. Therefore, the best classification is PSI with high confidence.
2018-02-02 Chinese
关于下属子公司注销医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shenzhen BGI Genomics Co., Ltd. regarding the cancellation of medical device registration certificates for certain products of its subsidiaries. It details the product names, registration numbers, cancellation dates, and reasons for cancellation, emphasizing the upgrade of sequencing platforms. The document is an official company announcement about regulatory compliance and product registration status, not a financial report, earnings release, or management discussion. It does not contain financial data, management changes, voting results, or legal proceedings. It is a regulatory announcement related to product registration and compliance. Given the content and length (2193 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-01-26 Chinese
2017年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a 2017 annual performance forecast (业绩预告) for Shenzhen BGI Genomics Co., Ltd. It covers the period from January 1, 2017 to December 31, 2017, indicating it relates to a full fiscal year. The document provides estimated net profit growth percentages and expected profit ranges but explicitly states that the forecast is unaudited and preliminary, with detailed audited financial data to be disclosed in the 2017 annual report. The document is short (1179 characters) and serves as a performance forecast rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of periodic financial results with key highlights only, not a full annual report or audited financial statements. FY 2017
2018-01-26 Chinese
公司章程（2018年1月）
Governance Information Classification · 100% confidence The document is titled "深圳华大基因股份有限公司章程" which translates to "Articles of Association of Shenzhen BGI Genomics Co., Ltd." It contains detailed company governance rules including chapters on general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting system, profit distribution, auditing, notices and announcements, mergers, capital changes, dissolution, amendments to the articles, and other provisions. The content is a comprehensive set of corporate bylaws and governance framework rather than a financial report or announcement. It does not contain financial statements, earnings data, or meeting results but rather the internal rules and structure of the company. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the articles, not a brief announcement or summary.
2018-01-19 Chinese
独立董事关于第一届董事会第十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding a board meeting decision to adjust the number of board members and amend the company bylaws. It references governance rules and company articles but does not contain financial data or audit information. It is related to board/management information about changes in the board structure. The document length is short and focused on governance matters, not a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG).
2018-01-19 Chinese
关于公司董事辞任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of several company directors, including details about their departure and its impact on the board composition. It does not contain financial data, audit information, or meeting materials, but specifically addresses changes in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification.
2018-01-19 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.